Products

Treatment of mild to moderately severe infections caused by penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci infections. Therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response.

For prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or Sydenham’s chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation.

Note: Oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or childbirth.

Treatment of mild to moderately severe infections caused by penicillin sensitive staphylococci, pneumococci, gonococci and haemolytic streptococci infections. Therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response.

For prophylactic use in recurrent streptococcal infections including the prevention of recurrence following rheumatic fever and/or Sydenham’s chorea and to prevent bacterial endocarditis in patients with rheumatic fever and/or congenital heart disease who are about to undergo dental or upper respiratory surgery or instrumentation.

Note: Oral penicillin should not be used as adjunctive prophylaxis for genitourinary instrumentation or surgery, lower intestinal tract surgery, sigmoidoscopy or childbirth.

Abelcet is indicated for the treatment of invasive fungal disease caused by organisms susceptible to amphotericin B

Pain

Aclor is indicated for the treatment of the following types of infections caused by or likely to be caused by susceptible organisms:

• Lower respiratory infections, including pneumonia, bronchitis and exacerbations of chronic bronchitis.
• Upper respiratory infections, including pharyngitis, tonsillitis and otitis media. Skin and skin structure infections.
• Urinary tract infections, including pyelonephritis and cystitis.

Treatment of type 2 diabetes mellitus inadequately controlled by diet and exercise:

• as monotherapy;
• as dual therapy to improve glycaemic control
• - in combination with metformin or sulfonylurea
• - in combination with insulin;
• as triple therapy to improve glycaemic control, in combination with metformin and sulfonylurea.

Treatment of hypertension. It may be used alone or in combination with thiazide diuretics. Sufficient data have not been provided to support the use of quinapril in renovascular hypertension.

Congestive heart failure. Adjunctive treatment of mild to moderate congestive heart failure when given concomitantly with a diuretic and/or cardiac glycoside.

Relief of unproductive, dry and intractable coughs associated with colds and flu.

Actiq is indicated for the management of breakthrough cancer pain in patients with malignancies who are already receiving and are tolerant to opioid therapy for their underlying persistent cancer pain.

Treatment of hypertension. Prophylaxis of chronic stable angina pectoris.

Moderate asthmatic attacks; chronic forms of asthma; asthma in patients with diminished cardiac reserve; chronic obstructive bronchitis with bronchospasm; bronchospasm during or after surgery, use during assisted ventilation with a respirator.

AGGRASTAT, in combination with heparin, is indicated for patients with unstable angina or non-Q-wave myocardial infarction to prevent cardiac ischaemic events.

Hypertension (mild, moderate to severe).

Treatment of osteoporosis, including glucocorticoid induced osteoporosis. Osteoporosis must be confirmed by the finding of low bone mass of at least two standard deviations below the gender specific mean for young adults, or by the presence of osteoporotic fracture. Paget's disease of bone.

Treatment of patients with multiple myeloma for whom oral therapy is not appropriate.

Palliative treatment of multiple myeloma and advanced ovarian adenocarcinoma.

Treatment of major depression

Main clinical manifestations of urate/uric acid deposition. These are gouty arthritis, skin tophi and/or renal involvement through crystal deposition or stone formation. Such clinical manifestations may occur in: idiopathic gout; uric acid lithiasis; acute uric acid nephropathy; neoplastic disease and myeloproliferative disease with high cell turnover rates, in which high urate levels occur either spontaneously or after cytotoxic therapy, certain enzyme disorders which lead to overproduction of urate and involve:

• • hypoxanthine guanine phosphoribosyltransferase including Lesch-Nyhan syndrome,
• • glucose 6-phosphatase including glycogen storage disease,
• • phosphoribosylpyrophosphate synthetase,
• • phosphoribosylpyrophosphate amidotransferase.

Management of recurrent mixed calcium oxalate renal stones in the presence of hyperuricosuria, when fluid, dietary and similar measures have failed.

Anxiety: the short-term symptomatic treatment of anxiety including treatment of anxious patients with some symptoms of depression; Panic Disorder: the treatment of panic disorder with or without some phobic avoidance, and for blocking or attenuation of panic attacks and phobias in patients who have agoraphobia with panic attacks.

Anxiety: the short-term symptomatic treatment of anxiety including treatment of anxious patients with some symptoms of depression; Panic Disorder: the treatment of panic disorder with or without some phobic avoidance, and for blocking or attenuation of panic attacks and phobias in patients who have agoraphobia with panic attacks.